EcoDrugPlus


Keyword(s):	Human Metabolites
Molecule Category	Free-form
EPA CompTox	DTXSID20949846

Keyword(s):

Human Metabolites

Molecule Category

Free-form

EPA CompTox

DTXSID20949846


InChI Key	TVCBDTCUOVDLNZ-UHFFFAOYSA-N
Smiles	O=C1C=NN(C(=S)N1)C2OC(CO)C(O)C2O
InChI	InChI=1/C8H11N3O5S/c12-2-3-5(14)6(15)7(16-3)11-8(17)10-4(13)1-9-11/h1,3,5-7,12,14-15H,2H2,(H,10,13,17)

InChI Key

TVCBDTCUOVDLNZ-UHFFFAOYSA-N

Smiles

O=C1C=NN(C(=S)N1)C2OC(CO)C(O)C2O

InChI

InChI=1/C8H11N3O5S/c12-2-3-5(14)6(15)7(16-3)11-8(17)10-4(13)1-9-11/h1,3,5-7,12,14-15H,2H2,(H,10,13,17)

Property Name	Value
Molecular Formula	C8H11N3O5S
Molecular Weight	261.04
AlogP	-1.68
Hydrogen Bond Acceptor	9.0
Hydrogen Bond Donor	4.0
Number of Rotational Bond	2.0
Polar Surface Area	120.86
Heavy Atoms	17.0

Property Name

Value

Molecular Formula

C8H11N3O5S

Molecular Weight

261.04

AlogP

-1.68

Hydrogen Bond Acceptor

9.0

Hydrogen Bond Donor

4.0

Number of Rotational Bond

2.0

Polar Surface Area

120.86

Heavy Atoms

17.0

Resources	Reference
CAS NUMBER	27089-56-1
NORMAN SUSDAT

Resources

Reference

CAS NUMBER

27089-56-1

NORMAN SUSDAT


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

(2,3,4,5-TETRAHYDRO)-3-THIOXO-2-(ß-D-RIBOFURANOSYL)-1,2,4-TRIAZIN-5-ONE

Structure

Physicochemical Descriptors

Cross References